HSG

Cloudphysician is a prominent provider of Smart-ICU services, utilizing a cloud-based platform to enhance critical care delivery. The company employs advanced technologies such as artificial intelligence, the Internet of Things, and predictive analytics to facilitate real-time clinical decision-making. This innovative approach supports early-stage diagnosis of critical diseases in adults and monitors immunization schedules and growth profiles of newborns, aimed at reducing neonatal mortality rates. By combining medical expertise with technology, Cloudphysician improves patient outcomes and offers hospitals and healthcare providers enhanced monitoring, support, and training, ultimately transforming the landscape of critical care in the healthcare industry.

Taiyi Guanjia is a company that combines technology and medical health innovation, aiming to enhance the insurance industry and create a robust medical and health ecosystem.

Twin Health, Inc. is a precision health company focused on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in India, Twin Health utilizes artificial intelligence and Internet-of-Things technologies to accurately measure and address metabolic health issues, which are often the underlying causes of chronic conditions. The platform incorporates sensors and advanced machine learning to analyze biosignals from wearables, predict metabolic outcomes, and provide personalized treatment recommendations tailored to each patient's metabolic profile. The company has secured significant funding from prominent venture capital firms and holds multiple patents related to its technology, positioning it as a leader in the field of metabolic health.

Neurowyzr specializes in brain healthcare by offering a platform that focuses on the detection, diagnosis, therapy, monitoring, and prevention of cognitive decline. The company's innovative approach provides healthcare providers with evidence-based tools aimed at enhancing awareness of brain health. By facilitating early intervention and promoting preventive measures, Neurowyzr seeks to transform societal attitudes towards brain health, ultimately enabling individuals to manage and maintain their cognitive well-being effectively.

HealiRNA develops infectious disease vaccines, tumor vaccines, cell therapy, and protein replacement. They provide mRNA drug research and development, production, clinical trial design, and data analysis services.

hoop is India’s first wellness brand for an active lifestyle! hoop’s wellness range is the answer India needs – effective pain, sleep, stress, workout products crafted with natural ingredients that feel amazing to use.

Spectrum Medical is a clinical mass spectrometry product platform that promotes clinical mass spectrometry detection technology to the general public. It has an experienced research and development, operations, and sales team, a standardized GMP production workshop, extensive experience in laboratory construction, and a mature laboratory management system. It provides with complete supporting kits in addition to mastering the core mass spectrometry hardware manufacturing technology and equipment integration development capabilities (maternal and child genetics, nutritional levels, therapeutic drug testing, metabolic monitoring, etc.).

NuProbe, Inc. is a genomics and molecular diagnostics company that focuses on noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in Shanghai, China, NuProbe has developed a platform that utilizes genetic toehold probes for quantitative PCR mutation detection. The company's innovative technology offers a Sample-In Answer-Out (SIAO) solution, which seamlessly integrates cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatic interpretation. This precision diagnostic technology is designed to facilitate the early detection of cancer and infectious diseases by accurately capturing disease signatures with high sensitivity and multiplexing capability, allowing healthcare professionals to initiate timely interventions for patients.

Us2.ai is a Singapore-based company that develops artificial intelligence-driven software and digital tools specifically for echocardiography. The company offers online solutions that streamline access to results from echocardiogram analyses and heart ultrasounds. Its machine learning platform automates the traditionally manual process of measuring and interpreting echocardiograms, enhancing the efficiency of cardiovascular research and clinical trials. By providing AI-based decision support tools, Us2.ai aims to save physicians time, improve the accuracy of clinical trials for pharmaceutical companies, and assist in the detection of conditions that are often overlooked or difficult to diagnose in hospital settings.

the first high-tech company in China to focus on the treatment of cerebrovascular disease, it has more than four years of product research and development, leading China's cerebrovascular disease intelligence in an all-around way. vertical field of diagnosis and treatment. It has become a well-known brain stroke intelligence diagnosis and treatment platform in China.

Virtue Diagnostics (Suzhou) Co., Ltd. is an in vitro diagnostic company established in 2019 and headquartered in Suzhou, China, with a research and development office in Singapore. The company specializes in developing advanced diagnostic technologies aimed at infectious diseases, cancer, and chronic diseases. Its offerings include clinical mass spectrometry, multiplex immunohistochemistry for pathology-based cancer detection, and a molecular and immunoassay platform. Through these technologies, Virtue Diagnostics aims to enhance disease detection and management, contributing to improved healthcare outcomes.

PT Lemonilo Indonesia Sehat operates as a retail platform that focuses on promoting healthier lifestyle choices through a diverse range of natural and affordable products. Established in 2016 and based in Jakarta Barat, Indonesia, Lemonilo offers an extensive selection of food products, such as snacks, vegetables, fruits, meat, seafood, baby food, and juices, alongside personal care items like face treatments, body care, dental hygiene products, and essential oils. The company is dedicated to providing products free from over 100 harmful synthetic ingredients and collaborates with small and medium-sized enterprises across Indonesia. Lemonilo aims to support the Indonesian population in leading healthier and more productive lives by making healthy living accessible and affordable through both its online platform and physical retail stores.

ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

SyMap Medical focuses on developing and manufacturing a proprietary catheter-based system for renal mapping and ablation, specifically aimed at treating hypertension and various other serious conditions, including heart failure, arrhythmia, and renal failure. The company's core technology platform is based on radiofrequency (RF) ablation, which is integral to its approach in renal nerve mapping and selective ablation. This innovative medical device is designed to enhance treatment options for patients suffering from these significant health issues.

Jianhai Technology is an AI whole-course management platform that provides users with post-hospital & post-diagnosis management services.

Genki Forest is a beverage company that focuses on producing sugar-free and low-calorie drinks, catering to consumers seeking healthy and flavorful options. The company specializes in manufacturing a range of beverages, including sugar-free tea and flavored seltzer water, created from natural ingredients. Genki Forest aims to provide affordable, health-conscious beverages, aligning with the growing demand for nutritious drink alternatives in the market.

Twin Health, Inc. is a precision health company focused on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in India, Twin Health utilizes artificial intelligence and Internet-of-Things technologies to accurately measure and address metabolic health issues, which are often the underlying causes of chronic conditions. The platform incorporates sensors and advanced machine learning to analyze biosignals from wearables, predict metabolic outcomes, and provide personalized treatment recommendations tailored to each patient's metabolic profile. The company has secured significant funding from prominent venture capital firms and holds multiple patents related to its technology, positioning it as a leader in the field of metabolic health.

MetWare is a developer of advanced metabolic technology that focuses on metabolism analysis and testing services for various health conditions, including cancer, metabolic disorders, and infectious diseases. The company utilizes innovative metabolomics technology to enhance life science research and medical applications. By providing clinical testing products and data analysis, MetWare aims to support healthcare professionals in delivering effective treatment to patients. Their commitment to applying cutting-edge technology in the medical field positions them as a significant contributor to improving health outcomes through detailed metabolic insights.

Yixue Jie is an app that offers medical information to medical workers. They provide information in these categories such as grassroots medical voice in the medical field, medical tumor channel, medical rheumatology and immunity channel, medical skin channel, medical cardiovascular channel, medical endocrinology channel, medical neurology channel, medical blood channel, medical pediatric channel, medical obstetrics and gynecology channel, medical respiratory channel, medical nephrology channel, digestive liver disease channel in medical circles, clinical pharmacy channel of the medical community, medical rare disease channel, medical cancer association, medical emergency and critical care channel, medical spirit channel, medical surgical channel, medical nursing channel, medical ophthalmology channel, medical infection channel, medical anesthesia channel, medical orthopedics channel, medical testing channel, medical image diagnosis and intervention channel, medical pathology channel, clinical decision assistant, a course in the medical field, and medical examination. It helps clinicians in clinical decision-making and professional advancement.

Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.

PT Lemonilo Indonesia Sehat operates as a retail platform that focuses on promoting healthier lifestyle choices through a diverse range of natural and affordable products. Established in 2016 and based in Jakarta Barat, Indonesia, Lemonilo offers an extensive selection of food products, such as snacks, vegetables, fruits, meat, seafood, baby food, and juices, alongside personal care items like face treatments, body care, dental hygiene products, and essential oils. The company is dedicated to providing products free from over 100 harmful synthetic ingredients and collaborates with small and medium-sized enterprises across Indonesia. Lemonilo aims to support the Indonesian population in leading healthier and more productive lives by making healthy living accessible and affordable through both its online platform and physical retail stores.

Genki Forest is a beverage company that focuses on producing sugar-free and low-calorie drinks, catering to consumers seeking healthy and flavorful options. The company specializes in manufacturing a range of beverages, including sugar-free tea and flavored seltzer water, created from natural ingredients. Genki Forest aims to provide affordable, health-conscious beverages, aligning with the growing demand for nutritious drink alternatives in the market.

Jianhai Technology is an AI whole-course management platform that provides users with post-hospital & post-diagnosis management services.

Neuracle is a prominent enterprise in China's neuroscience sector, specializing in neural monitoring and diagnostic technology. Leveraging advanced brain-machine interface technology developed in collaboration with Tsinghua University, Neuracle focuses on innovative research across neuroscience, psychology, and neuroengineering. The company provides comprehensive solutions for the diagnosis, treatment, and rehabilitation of clinical neurological diseases. Its product offerings include digital electroencephalographs that allow healthcare institutions to monitor patients' brain bioelectricity levels and facilitate accurate diagnoses of neural conditions. Neuracle's contributions span various fields, including clinical medicine and management marketing, and the company's research and development efforts have garnered recognition from experts in neuroscience and clinical medicine both domestically and internationally.

ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

WeDoctor is a prominent medical health technology platform founded in 2010 by Liao Jieyuan and his team. The company aims to enhance access to healthcare by leveraging technology to provide a comprehensive range of services. Its mobile application allows users to connect with hospitals and doctors, schedule appointments, and access medical advice and ratings for healthcare providers. By integrating both online and offline medical services, WeDoctor aspires to serve as a health management organization, facilitating improved healthcare experiences for millions of families. The platform emphasizes a user-friendly approach to healthcare, making essential medical services readily available and efficient.

Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.

NuProbe, Inc. is a genomics and molecular diagnostics company that focuses on noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in Shanghai, China, NuProbe has developed a platform that utilizes genetic toehold probes for quantitative PCR mutation detection. The company's innovative technology offers a Sample-In Answer-Out (SIAO) solution, which seamlessly integrates cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatic interpretation. This precision diagnostic technology is designed to facilitate the early detection of cancer and infectious diseases by accurately capturing disease signatures with high sensitivity and multiplexing capability, allowing healthcare professionals to initiate timely interventions for patients.

Virta Health Corp. is an online specialty medical clinic dedicated to reversing type 2 diabetes without the use of medications or surgery. Founded in 2014 and based in San Francisco, California, the company utilizes a combination of nutritional biochemistry, clinical expertise, data science, and digital solutions to deliver its innovative treatment. Through its continuous remote care platform, Virta provides extensive medical and behavioral support, which has shown significant results in clinical trials; 60% of enrolled patients achieved diabetes reversal after one year, while 94% of insulin users reduced or eliminated their insulin intake. The benefits of Virta's approach extend beyond diabetes, leading to improvements in blood pressure, inflammation, liver function, and body mass index (BMI), thereby transforming the lives of individuals affected by type 2 diabetes.

Genki Forest is a beverage company that focuses on producing sugar-free and low-calorie drinks, catering to consumers seeking healthy and flavorful options. The company specializes in manufacturing a range of beverages, including sugar-free tea and flavored seltzer water, created from natural ingredients. Genki Forest aims to provide affordable, health-conscious beverages, aligning with the growing demand for nutritious drink alternatives in the market.

Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.

SiBionics is a medtech company based in Shenzhen, China, focused on the research and development of active implantable medical devices and medical artificial intelligence. The company specializes in creating innovative solutions for various health conditions, including retinitis pigmentosa, diabetes, cardiovascular diseases, and gastrointestinal tumors. SiBionics develops artificial intelligence technologies for medical imaging and implantable devices, including retinal electrical stimulators and continuous glucose monitors. Their work also encompasses health management, disease screening, and diagnostics, using approaches such as visual coding, medical imaging AI, and big data analytics to enhance patient care and address chronic diseases. Through these advancements, SiBionics aims to provide cost-effective products that improve long-term monitoring and treatment options in the medical field.

Qure.ai Technologies Private Limited specializes in developing artificial intelligence software for the healthcare sector, focusing on medical imaging to enhance disease diagnosis from radiology and pathology images. Founded in 2016 and headquartered in Mumbai, India, with a presence in New York, the company offers tools such as qXR, which automates chest X-ray interpretation to identify abnormal findings, including signs of tuberculosis. Qure.ai also provides qER, which assists in triaging critical head CT scans and offers tools for monitoring traumatic brain injury and reporting. By leveraging deep learning solutions, Qure.ai aims to improve the accuracy of diagnoses and make healthcare more affordable and accessible, ultimately allowing healthcare professionals to dedicate more time to patient care.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Eko.ai Pte. Ltd. is a Singapore-based company that specializes in artificial intelligence software aimed at the early detection and treatment of heart disease. Founded in 2017, the company focuses on democratizing echocardiography and ultrasound imaging to enhance cardiovascular risk assessment. Eko.ai employs machine learning to automate processes, providing research teams with fully classified, machine learning-ready databases and a variety of tools, including segmentation and validation models. By collaborating with clinician scientists, sonographers, and deep learning experts, Eko.ai serves laboratories worldwide, aiming to improve productivity and patient outcomes within hospital systems.

Developer of dental imaging technology and dental clinic management software. The company's software helps dental professionals accurately diagnose patient conditions through oral CT scanning, as well as keep track of patient records and appointments, enabling dental professionals to provide treatment more efficiently.

BGI is a biotechnology company specializing in genomics. It provides genome sequencing and genetic testing services to research institutions and healthcare professionals worldwide. The company's offerings include bioinformatics, multi-omics solutions, and related tools, catering to a diverse range of clients such as pharmaceutical companies and academic institutions. BGI's work has contributed significantly to genetic and genomic research, with notable collaborations including Eli Lilly and Company, Merck, Pfizer Inc., and the Bill & Melinda Gates Foundation.

Yaoyanshe is a Shanghai-based company established in 2012 that operates a technology platform focused on the pharmaceutical research and development industry. It develops an application that facilitates value sharing and trading, providing patients with up-to-date information on treatments and drugs. The platform also supports industry professionals by offering services such as clinical monitoring, project management, biostatistics, and pharmacovigilance. Additionally, it includes features for credit assessments and research project competition analysis, aiming to address critical challenges in the sector and enhance the effectiveness of pharmaceutical R&D. Through its comprehensive database, Yaoyanshe enables medical professionals and patients to access vital healthcare information efficiently.

Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".

Burning Rock Biotech Limited specializes in developing and providing cancer therapy selection tests in the People's Republic of China. The company offers a range of next-generation sequencing-based tests applicable to various cancer types, including lung, gastrointestinal, prostate, breast, and others, using tissue and liquid biopsy samples. Its key products include OncoScreen Plus for therapy and immunotherapy guidance, LungPlasma for non-small cell lung cancer, ColonCore for gastrointestinal cancers, and HRDCore for homologous recombination deficiency testing. Burning Rock collaborates with major pharmaceutical companies like AstraZeneca and BeiGene for clinical trials and research studies, primarily through central laboratory and companion diagnostics services. Founded in 2014, the company is headquartered in Guangzhou, with a focus on providing individualized cancer treatment guidance using NGS and biomedical informatics.

Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.

VoxelCloud Inc. is a company specializing in cloud computing and artificial intelligence solutions aimed at enhancing the interpretation of medical images and clinical data for healthcare professionals. Founded in 2015 and headquartered in Los Angeles, California, VoxelCloud provides automated medical image analysis and diagnostics services utilizing proprietary algorithms and deep learning techniques. The company focuses on critical clinical areas, including lung cancer, diabetic retinopathy, coronary heart disease, and liver disease, ensuring that medical practitioners receive accurate and timely insights. In addition to its Los Angeles base, VoxelCloud has offices in Shanghai and Suzhou, China, and maintains a research and development team in Phoenix, further expanding its capabilities in the healthcare sector.

Infervision is an artificial intelligence company based in Beijing that specializes in medical imaging diagnosis. Utilizing deep learning technology and computer vision, Infervision develops innovative solutions to assist in the diagnosis of cancers and other medical conditions. The company launched the world's first artificial intelligence precise healthcare platform and has introduced intelligent X-ray and CT diagnosis products, which are currently undergoing trials in several prominent hospitals in China. Infervision collaborates closely with top medical institutions, fostering strong partnerships with nearly 20 Tertiary Grade A hospitals, including Peking Union Medical College Hospital and Tongji Medical College. This collaboration aims to enhance the integration of medical data, technology, and application scenarios, ultimately providing more accurate and efficient diagnostic tools for healthcare professionals. Through its research and development efforts, Infervision is committed to advancing the field of artificial intelligence in healthcare, thereby improving patient outcomes and reducing costs.

Medlinker operates as a social networking platform specifically designed for certified doctors, enabling them to connect with peers and access high-quality medical information. The platform facilitates knowledge sharing among healthcare professionals, allowing users to exchange experiences and insights. It offers various features, including medical quizzes, case mapping, and anonymous social circles, aimed at enhancing collaboration within the medical community. Additionally, Medlinker connects verified doctors with healthcare institutions, pharmaceutical companies, patients, and insurance firms, streamlining the process for patients to book medical appointments and submit inquiries to the medical community. Through these functionalities, Medlinker aims to improve the efficiency of healthcare interactions and support physicians in their professional development.

Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with a lab in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the tumor microenvironment using fresh, unmodified human tumor fragments and autologous blood samples, enabling oncologists and drug developers to test individual tumors and predict patient response to treatments with higher accuracy. Farcast's mission is to illuminate personalized treatment paths for cancer patients by providing precise, patient-specific data.

NuProbe, Inc. is a genomics and molecular diagnostics company that focuses on noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in Shanghai, China, NuProbe has developed a platform that utilizes genetic toehold probes for quantitative PCR mutation detection. The company's innovative technology offers a Sample-In Answer-Out (SIAO) solution, which seamlessly integrates cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatic interpretation. This precision diagnostic technology is designed to facilitate the early detection of cancer and infectious diseases by accurately capturing disease signatures with high sensitivity and multiplexing capability, allowing healthcare professionals to initiate timely interventions for patients.

Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.

Infervision is an artificial intelligence company based in Beijing that specializes in medical imaging diagnosis. Utilizing deep learning technology and computer vision, Infervision develops innovative solutions to assist in the diagnosis of cancers and other medical conditions. The company launched the world's first artificial intelligence precise healthcare platform and has introduced intelligent X-ray and CT diagnosis products, which are currently undergoing trials in several prominent hospitals in China. Infervision collaborates closely with top medical institutions, fostering strong partnerships with nearly 20 Tertiary Grade A hospitals, including Peking Union Medical College Hospital and Tongji Medical College. This collaboration aims to enhance the integration of medical data, technology, and application scenarios, ultimately providing more accurate and efficient diagnostic tools for healthcare professionals. Through its research and development efforts, Infervision is committed to advancing the field of artificial intelligence in healthcare, thereby improving patient outcomes and reducing costs.

Medlinker operates as a social networking platform specifically designed for certified doctors, enabling them to connect with peers and access high-quality medical information. The platform facilitates knowledge sharing among healthcare professionals, allowing users to exchange experiences and insights. It offers various features, including medical quizzes, case mapping, and anonymous social circles, aimed at enhancing collaboration within the medical community. Additionally, Medlinker connects verified doctors with healthcare institutions, pharmaceutical companies, patients, and insurance firms, streamlining the process for patients to book medical appointments and submit inquiries to the medical community. Through these functionalities, Medlinker aims to improve the efficiency of healthcare interactions and support physicians in their professional development.

MedGenome is a company focused on advancing global health through its sequencing genomics-based diagnostics and research platform. This platform utilizes genomics technologies, bioinformatics, computing, and big data analytics to explore the genetic underpinnings of various diseases, including cancer, metabolic disorders, eye disorders, and rare diseases. MedGenome offers high-end genetic diagnostic tests across multiple categories such as immuno-oncology, infectious diseases, reproductive health, and rare diseases. By leveraging the genetic diversity of large populations, the company aims to provide valuable insights that support the healthcare industry in understanding diseases at both genetic and molecular levels.

Hong Kong Asia Heart Centre is a cardiovascular specialist chain that provides various cardiovascular assessment and surgical services. Founded in 1999, The Hong Kong Asian Heart Center has a professional medical team with many years of experience in the treatment of heart disease.

Suburban Diagnostics operates diagnostic centers in Maharashtra, offering a comprehensive range of services in pathology, radiology, and cardiology. The company focuses on delivering accurate diagnoses and precise reporting to enhance patient care. In addition to its diagnostic services, Suburban Diagnostics provides health check-ups, ensuring a holistic approach to health management for its clients. Through its commitment to quality and precision, the company aims to support healthcare providers in improving patient outcomes.

Infervision is an artificial intelligence company based in Beijing that specializes in medical imaging diagnosis. Utilizing deep learning technology and computer vision, Infervision develops innovative solutions to assist in the diagnosis of cancers and other medical conditions. The company launched the world's first artificial intelligence precise healthcare platform and has introduced intelligent X-ray and CT diagnosis products, which are currently undergoing trials in several prominent hospitals in China. Infervision collaborates closely with top medical institutions, fostering strong partnerships with nearly 20 Tertiary Grade A hospitals, including Peking Union Medical College Hospital and Tongji Medical College. This collaboration aims to enhance the integration of medical data, technology, and application scenarios, ultimately providing more accurate and efficient diagnostic tools for healthcare professionals. Through its research and development efforts, Infervision is committed to advancing the field of artificial intelligence in healthcare, thereby improving patient outcomes and reducing costs.

Burning Rock Biotech Limited specializes in developing and providing cancer therapy selection tests in the People's Republic of China. The company offers a range of next-generation sequencing-based tests applicable to various cancer types, including lung, gastrointestinal, prostate, breast, and others, using tissue and liquid biopsy samples. Its key products include OncoScreen Plus for therapy and immunotherapy guidance, LungPlasma for non-small cell lung cancer, ColonCore for gastrointestinal cancers, and HRDCore for homologous recombination deficiency testing. Burning Rock collaborates with major pharmaceutical companies like AstraZeneca and BeiGene for clinical trials and research studies, primarily through central laboratory and companion diagnostics services. Founded in 2014, the company is headquartered in Guangzhou, with a focus on providing individualized cancer treatment guidance using NGS and biomedical informatics.

Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with a lab in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the tumor microenvironment using fresh, unmodified human tumor fragments and autologous blood samples, enabling oncologists and drug developers to test individual tumors and predict patient response to treatments with higher accuracy. Farcast's mission is to illuminate personalized treatment paths for cancer patients by providing precise, patient-specific data.

Health 724 is a health service provider based on users, health managers, and health products. They offer direct supply of health products to users who are concerned about their own and their families' health, as well as customized health solutions.

Dongri Zhongyi Guan is a chain organisation for TCM diagnosis and treatment that integrates Internet technologies with the fundamental principles of traditional TCM. Pediatric illnesses, andrological illnesses such as impotence, early ejaculation, prostate, etc., spleen and stomach illnesses, colds and flu, neck and lumbar illnesses, liver and gallbladder illnesses, and other illnesses are all treated by them.

SyMap Medical focuses on developing and manufacturing a proprietary catheter-based system for renal mapping and ablation, specifically aimed at treating hypertension and various other serious conditions, including heart failure, arrhythmia, and renal failure. The company's core technology platform is based on radiofrequency (RF) ablation, which is integral to its approach in renal nerve mapping and selective ablation. This innovative medical device is designed to enhance treatment options for patients suffering from these significant health issues.

Burning Rock Biotech Limited specializes in developing and providing cancer therapy selection tests in the People's Republic of China. The company offers a range of next-generation sequencing-based tests applicable to various cancer types, including lung, gastrointestinal, prostate, breast, and others, using tissue and liquid biopsy samples. Its key products include OncoScreen Plus for therapy and immunotherapy guidance, LungPlasma for non-small cell lung cancer, ColonCore for gastrointestinal cancers, and HRDCore for homologous recombination deficiency testing. Burning Rock collaborates with major pharmaceutical companies like AstraZeneca and BeiGene for clinical trials and research studies, primarily through central laboratory and companion diagnostics services. Founded in 2014, the company is headquartered in Guangzhou, with a focus on providing individualized cancer treatment guidance using NGS and biomedical informatics.

MedGenome is a company focused on advancing global health through its sequencing genomics-based diagnostics and research platform. This platform utilizes genomics technologies, bioinformatics, computing, and big data analytics to explore the genetic underpinnings of various diseases, including cancer, metabolic disorders, eye disorders, and rare diseases. MedGenome offers high-end genetic diagnostic tests across multiple categories such as immuno-oncology, infectious diseases, reproductive health, and rare diseases. By leveraging the genetic diversity of large populations, the company aims to provide valuable insights that support the healthcare industry in understanding diseases at both genetic and molecular levels.

Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".

KFit Holdings Pte Ltd operates an online platform and mobile application that allows users to discover, plan, and book a range of fitness, beauty, and wellness activities at various participating outlets in cities such as Manila, Kuala Lumpur, Singapore, and Hong Kong. The company offers a monthly membership known as the KFit Fitness Pass, which permits members to access up to ten fitness classes and activities each month for a fixed fee. By partnering with studios, gyms, spas, and salons, KFit provides a flexible solution for individuals seeking diverse workout options and wellness services. Established in 2012, KFit is headquartered in Singapore and aims to enhance the fitness experience by providing easy access to a variety of activities tailored to members' preferences.

EndoChoice is a medical technology company specializing in the design and commercialization of products and services for gastrointestinal (GI) care. Headquartered in Alpharetta, Georgia, EndoChoice offers a comprehensive range of products, including single-use devices, infection control solutions, diagnostics, and advanced imaging systems. The company's proprietary product portfolio features the Full Spectrum Endoscopy™ System, known as Fuse™, which includes colonoscopes and gastroscopes equipped with multiple imagers. This innovative system enables physicians to achieve a 330-degree field of view, significantly improving the detection of polyps compared to traditional endoscopes. With a direct sales organization serving over 2,000 customers in the United States and partnerships with 34 distributors globally, EndoChoice has established a strong presence in the market. Founded in 2008, the company experienced rapid growth and was recognized by Inc. Magazine as one of the fastest-growing companies in the U.S. before its acquisition by Boston Scientific in 2016.

Medlinker operates as a social networking platform specifically designed for certified doctors, enabling them to connect with peers and access high-quality medical information. The platform facilitates knowledge sharing among healthcare professionals, allowing users to exchange experiences and insights. It offers various features, including medical quizzes, case mapping, and anonymous social circles, aimed at enhancing collaboration within the medical community. Additionally, Medlinker connects verified doctors with healthcare institutions, pharmaceutical companies, patients, and insurance firms, streamlining the process for patients to book medical appointments and submit inquiries to the medical community. Through these functionalities, Medlinker aims to improve the efficiency of healthcare interactions and support physicians in their professional development.

Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".

In China, almost every doctor must face overloaded with work. The number of patients they received a day or even a week,the number of foreign doctors will be reception. In addition to China's large population of natural conditions, the unity of the health care system, pattern, so difficult and tense doctor-patient relationship and other issues remain unresolved.

Cloudnine Hospitals, founded in 2007 by Dr. R. Kishore Kumar and his co-founders, is a leading healthcare provider in India specializing in maternal, gynecological, neonatal, and pediatric care. With a mission to elevate healthcare standards, Cloudnine aims to transform societal attitudes towards pregnancy, promoting the idea that it is a celebration of life rather than an illness. The organization offers a wide range of services, including support for infertility, conception, and delivery, while ensuring comprehensive medical care throughout pregnancy and beyond. Cloudnine operates over 20 facilities across major cities such as Bengaluru, Chennai, Gurgaon, Mumbai, Pune, and Chandigarh, with plans for further expansion to enhance access to quality healthcare for women and children throughout India. The hospital group is committed to maintaining international standards of care, reflecting its vision of providing world-class healthcare services.

ASG Eye Hospitals is a prominent chain of super-specialty eye hospitals operating across various cities in India. Founded by experts from AIIMS, New Delhi, the organization has expanded its reach in regions including North and North East India, Rajasthan, Uttar Pradesh, Madhya Pradesh, Chhattisgarh, Jharkhand, Bihar, and Assam. The hospital network offers comprehensive ophthalmic care, specializing in a wide array of ocular sub-specialties, such as cataracts, diabetic retinopathy, glaucoma, macular degeneration, and eye tumors. ASG Eye Hospitals is committed to providing advanced diagnosis, treatment, and surgical services utilizing cutting-edge technology. The institution prides itself on employing highly skilled and trained professionals, including world-class surgeons with extensive surgical experience and expertise, ensuring patients receive top-tier eye care to help them regain their vision.

EndoChoice is a medical technology company specializing in the design and commercialization of products and services for gastrointestinal (GI) care. Headquartered in Alpharetta, Georgia, EndoChoice offers a comprehensive range of products, including single-use devices, infection control solutions, diagnostics, and advanced imaging systems. The company's proprietary product portfolio features the Full Spectrum Endoscopy™ System, known as Fuse™, which includes colonoscopes and gastroscopes equipped with multiple imagers. This innovative system enables physicians to achieve a 330-degree field of view, significantly improving the detection of polyps compared to traditional endoscopes. With a direct sales organization serving over 2,000 customers in the United States and partnerships with 34 distributors globally, EndoChoice has established a strong presence in the market. Founded in 2008, the company experienced rapid growth and was recognized by Inc. Magazine as one of the fastest-growing companies in the U.S. before its acquisition by Boston Scientific in 2016.

Betta Pharmaceuticals, established in 2003, is a leading Chinese pharmaceutical company specializing in the research, development, manufacturing, and marketing of innovative medicines. Its primary focus is on treating severe diseases like malignant tumors, diabetes, and cardio-cerebrovascular diseases. Betta's flagship product, Icotinib Hydrochloride (Conmana), is a pioneering targeted anti-cancer drug developed in China, used for treating non-small-cell lung cancer. The company has a strong pipeline with over 20 new drug development projects and holds more than 100 authorized patents. Betta Pharmaceuticals is headquartered in Hangzhou, with additional facilities in Beijing, and employs nearly 1,000 people, including many returned PhD holders. It has successfully listed on the GEM of the Shenzhen Stock Exchange and has received numerous awards for its innovative work, including the First Prize of National Prize for Progress in Science and Technology.

Suburban Diagnostics operates diagnostic centers in Maharashtra, offering a comprehensive range of services in pathology, radiology, and cardiology. The company focuses on delivering accurate diagnoses and precise reporting to enhance patient care. In addition to its diagnostic services, Suburban Diagnostics provides health check-ups, ensuring a holistic approach to health management for its clients. Through its commitment to quality and precision, the company aims to support healthcare providers in improving patient outcomes.

BGI is a biotechnology company specializing in genomics. It provides genome sequencing and genetic testing services to research institutions and healthcare professionals worldwide. The company's offerings include bioinformatics, multi-omics solutions, and related tools, catering to a diverse range of clients such as pharmaceutical companies and academic institutions. BGI's work has contributed significantly to genetic and genomic research, with notable collaborations including Eli Lilly and Company, Merck, Pfizer Inc., and the Bill & Melinda Gates Foundation.

Glocal Healthcare is focused on improving healthcare delivery, particularly in rural areas of India, by utilizing a technology-enabled platform. The company operates a network of hospitals that offer a range of services, including outpatient and inpatient care, emergency services, and obstetric treatment, alongside digital dispensaries and telemedicine options. Glocal’s approach makes healthcare more affordable, accessible, and accountable, even in regions where traditional healthcare providers face challenges. It has developed two mobile applications, hellolyf and hellolyf Dr, which facilitate healthcare access for patients. With 250 telemedicine and IoT-based digital clinics, as well as ten hospitals, Glocal Healthcare aims to enhance the speed and effectiveness of treatment, ensuring better health outcomes for communities in need.

Moolchand Healthcare is a prominent healthcare service provider based in Delhi, India, specializing in multi-specialty hospital operations. The organization features specialty hospitals staffed with internationally trained and globally recognized physicians, ensuring high-quality medical care. Moolchand Healthcare is committed to utilizing state-of-the-art technology and clinical innovations, providing patients with access to advanced treatment options for various life-threatening and acute physical ailments. The infrastructure of Moolchand Healthcare is designed to meet world-class standards, enhancing the overall patient experience and outcomes.

Hinacom Software and Technology, Ltd. is a healthcare IT company specializing in medical imaging and information management solutions. Based in Beijing, China, the company offers its miPlatform, an integrated medical imaging suite that encompasses various components such as Enterprise PACS/RIS, Regional PACS, TeleMed/TeleRad, web-based 3D processing, clinical image-based conferencing, and mobile imaging systems. The Enterprise PACS/RIS system is designed with a browser/server architecture to enhance workflow management, while the Regional PACS system facilitates patient-centered collaboration for medical imaging services across multiple hospitals in a region. The TeleMed/TeleRad system enables image transmission, viewing, and conferencing within web environments. Hinacom's solutions are utilized by hospitals and teleradiology projects in China, as well as by radiologists and clinicians in the United States, Europe, and Southeast Asia. Founded in 2008, the company has established itself as a key player in the medical imaging industry.

Moolchand Healthcare is a prominent healthcare service provider based in Delhi, India, specializing in multi-specialty hospital operations. The organization features specialty hospitals staffed with internationally trained and globally recognized physicians, ensuring high-quality medical care. Moolchand Healthcare is committed to utilizing state-of-the-art technology and clinical innovations, providing patients with access to advanced treatment options for various life-threatening and acute physical ailments. The infrastructure of Moolchand Healthcare is designed to meet world-class standards, enhancing the overall patient experience and outcomes.

Glocal Healthcare is focused on improving healthcare delivery, particularly in rural areas of India, by utilizing a technology-enabled platform. The company operates a network of hospitals that offer a range of services, including outpatient and inpatient care, emergency services, and obstetric treatment, alongside digital dispensaries and telemedicine options. Glocal’s approach makes healthcare more affordable, accessible, and accountable, even in regions where traditional healthcare providers face challenges. It has developed two mobile applications, hellolyf and hellolyf Dr, which facilitate healthcare access for patients. With 250 telemedicine and IoT-based digital clinics, as well as ten hospitals, Glocal Healthcare aims to enhance the speed and effectiveness of treatment, ensuring better health outcomes for communities in need.

Attenti, formerly known as Dmatek, is a global provider of remote monitoring technologies, primarily serving the criminal justice sector and senior housing markets. The company develops, manufactures, and supplies innovative presence and location verification solutions, including wireless monitoring systems that integrate wandering prevention, nurse call functions, and resident well-being monitoring. Attenti's product offerings feature solutions such as automatic alerts for residents approaching monitored areas, streamlined communication systems for staff, and tools for asset tracking and device management. Founded in 1990 and headquartered in Tel Aviv, Israel, Attenti has expanded its operations internationally, with a presence in the United States, Latin America, Europe, and the Pacific Rim. The company partners with public and private organizations, monitoring service providers, and government agencies across more than 25 countries.